Omeros (OMER) Current Taxes (2021 - 2026)
Omeros (OMER) posted Current Taxes of $1.1 million for Q1 2026, little changed sequentially from $1.1 million in Q4 2025.
Analysis
Omeros (OMER) Current Taxes (2021 - 2026) Analysis & Trends
Omeros has reported Current Taxes for 6 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Current Taxes changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (changed N/A YoY) and the FY2025 annual result came in at $1.1 million, up 1983.64% from the prior year.
- Current Taxes was little changed at $1.1 million in Q1 2026 per OMER's latest filing, from $1.1 million in the prior quarter.
- Over five years, Current Taxes peaked at $4.9 million in Q4 2022 and troughed at $55000.0 in Q4 2024.
- A 5-year average of $2.1 million and a median of $1.2 million in 2023 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2022 and 2025: Current Taxes soared 1341.12% in 2022, then soared 1983.64% in 2025.
- Over 5 years, Current Taxes stood at $4.9 million in 2022, then plunged by 74.79% to $1.2 million in 2023, then sank by 95.52% to $55000.0 in 2024, then jumped by 1983.64% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $1.1 million, $1.1 million, and $55000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | 656,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 656,000.00 |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2023 | 1.23 Mn |
| Jun 30, 2023 | 1.23 Mn |
| Mar 31, 2023 | 4.87 Mn |
| Dec 31, 2022 | 4.87 Mn |
| Dec 31, 2021 | 338,000.00 |